INTANGIBLE ASSETS, NET (Details Narrative)	12 Months Ended
	Dec. 31, 2016 USD ($) Number	Dec. 31, 2015 USD ($)	Dec. 31, 2014 USD ($)
Finite-Lived Intangible Assets [Line Items]
Amortization expense | $	$ 54,545	$ 32,441	$ 23,480
Number of issued patents	17
Approved Hormone Therapy Drug Candidate Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Useful Life	20 years
Utility Patent Progesterone and Estradiol Products [Member]
Finite-Lived Intangible Assets [Line Items]
Number of issued patents	13
Utility Patent TX-004HR [Member]
Finite-Lived Intangible Assets [Line Items]
Number of issued patents	2
Opera Software Patent [Member]
Finite-Lived Intangible Assets [Line Items]
Number of issued patents	1
Utility Patent Pipeline Transdermal Patch Technology [Member]
Finite-Lived Intangible Assets [Line Items]
Number of issued patents	1